Targeting Natural Killer Cells to Acute Myeloid Leukemia in Vitro With a CD16 X 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-0505
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2013
Authors
Publisher
American Association for Cancer Research (AACR)